Valuation Lisata Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
0.9959 ^USD	-0.91%		-3.31%	-46.46%

10-14	Lisata Therapeutics, Inc. Announces Appointment of Jeffrey Farrow as Class III Director and Audit Committee Member, Effective October 13, 2026	CI
10-05	Lisata Therapeutics Subsidiary Marea Therapeutics Doses First Patient In Phase 2 Clinical Trial Of MAR002 For The Treatment Of Acromegaly	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	50.31	19.88	22.22	25.02	16.41	8.974	-	-
Change	-	-60.48%	11.75%	12.58%	-34.42%	-45.3%	-	-
Enterprise Value (EV)	50.31	19.88	22.22	8.808	0.4506	8.974	8.974	8.974
Change	-	-60.48%	11.75%	-60.36%	-94.88%	1,891.73%	0%	0%
P/E	-1.68x	-0.24x	-1.06x	-1.24x	-0.97x	-0.91x	-0.86x	-1.02x
PBR	-	-	-	0.85x	1.13x	-	-	-
PEG	-	-0x	0x	0.18x	0x	0x	-0.13x	0.1x
Capitalization / Revenue	-	-	-	25x	96.5x	-	-	1.25x
EV / Revenue	-	-	-	0x	0x	-	-	1.25x
EV / EBITDA	-0x	-0x	-0x	-0x	-0x	-0.35x	-0.31x	-0.35x
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.35x	-0.31x	-0.35x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.5	-10.47	-2.58	-2.4	-1.91	-1.09	-1.16	-0.98
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	1	0.17	-	-	7.2
EBITDA ¹	-29	-57.53	-25.52	-22.24	-18.06	-25.4	-29.3	-25.9
EBIT ¹	-29.05	-57.6	-25.71	-22.41	-18.21	-25.4	-29.3	-25.9
Net income ¹	-27.47	-54.22	-20.84	-19.98	-16.59	-18.3	-21.1	-18.7
Net Debt	-	-	-	-16.21	-15.96	-	-	-
Reference price ²	12.6240	2.5300	2.7300	2.9800	1.8600	0.9959	0.9959	0.9959
Nbr of stocks (in thousands)	3,985	7,860	8,139	8,395	8,821	9,011	-	-
Announcement Date	3/22/22	3/30/23	2/29/24	2/27/25	3/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LISATA THERAPEUTICS, INC.	-0.91x	-	-	-	8.97M
WUXI APPTEC CO., LTD.	18.83x	6.63x	13.18x	1.58%	64.69B
ARGENX SE	30.16x	8x	26.2x	0.05%	54.78B
LONZA GROUP AG	36.79x	6.53x	19.51x	0.88%	53.49B
IQVIA HOLDINGS INC.	35.59x	3.45x	14.87x	-.--%	45.98B
BEONE MEDICINES AG	49.71x	5.74x	31.52x	-.--%	42.94B
REVOLUTION MEDICINES, INC.	-19.41x	187.75x	-20.66x	-.--%	40.08B
CELLTRION, INC.	28.93x	8.21x	21.27x	0.37%	33.52B
WUXI BIOLOGICS (CAYMAN) INC.	27.67x	5.83x	15.12x	-.--%	23.97B
GENMAB A/S	32.66x	5.97x	20.09x	-.--%	23.67B
Average	24.00x	26.46x	15.68x	0.32%	38.31B
Weighted average by Cap.	26.72x	25.33x	15.90x	0.43%